InhaleRx Ltd: Half Yearly Report and Accounts
InhaleRx Ltd Hosts Investor Webinar on Future Strategies
InhaleRx to Focus on Breakthrough Cancer Pain for Phase 2 Trial of Cannabinoid Analgesic
InhaleRx Secures Nearly AU$550,000 R&D Tax Incentive Prepayment
InhaleRX Completes Phase One Trial for Pain Medication Device
InhaleRx Files Ethics Application for Panic Disorder Trial
No Data
No Data